Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -0.61%163.9B | 209.88%164.9B | 294.05%53.21B | -133.84%-27.42B | -33.18%81.03B | 6.27%121.27B | 8.79%114.12B | -1.59%104.9B | -3.27%106.59B | -4.56%110.2B |
Net profit before non-cash adjustment | -27.89%77.08B | 105.00%106.88B | 162.44%52.14B | -331.48%-83.51B | -35.02%36.08B | 9.96%55.52B | 12.24%50.49B | -8.35%44.99B | 15.54%49.08B | 8.66%42.48B |
Total adjustment of non-cash items | 58.54%80.18B | 315.50%50.57B | -126.64%-23.47B | 79.50%88.09B | -32.05%49.08B | 8.13%72.22B | 7.61%66.79B | 5.57%62.07B | -17.41%58.79B | -4.40%71.18B |
-Depreciation and amortization | 16.29%76.82B | 28.83%66.06B | -6.41%51.28B | 1.56%54.79B | 3.30%53.95B | -0.64%52.23B | -1.40%52.57B | 0.30%53.31B | -0.21%53.15B | 2.80%53.26B |
-Reversal of impairment losses recognized in profit and loss | -64.94%4.68B | 19.95%13.34B | -61.37%11.12B | 253.57%28.79B | 2.66%8.14B | -6.96%7.93B | 8.39%8.52B | -28.31%7.86B | 51.56%10.97B | 34.36%7.24B |
-Share of associates | 73.77%-2.29B | 60.14%-8.71B | -86.41%-21.85B | -141.79%-11.72B | 32.10%-4.85B | -19.48%-7.14B | -206.78%-5.98B | 71.12%-1.95B | 18.33%-6.74B | -30.01%-8.26B |
-Disposal profit | -14.42%629M | 103.27%735M | -15,277.70%-22.46B | -34.22%148M | -62.37%225M | 278.48%598M | -92.68%158M | -13.93%2.16B | 365.80%2.51B | -6.60%538M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---7.04B | ---- |
-Other non-cash items | 101.58%330M | 49.81%-20.86B | -358.31%-41.55B | 291.71%16.09B | -145.09%-8.39B | 61.54%18.61B | 1,584.21%11.52B | -88.49%684M | -67.70%5.95B | -20.12%18.4B |
Changes in working capital | -10.71%6.64B | -69.68%7.44B | 176.69%24.54B | -676.58%-32B | 36.37%-4.12B | -104.29%-6.48B | -47.03%-3.17B | -68.04%-2.16B | 63.03%-1.28B | -281.68%-3.47B |
-Change in receivables | -19.12%50.73B | 781.35%62.73B | -48.08%-9.21B | -131.64%-6.22B | 613.86%19.65B | -4,507.23%-3.82B | 96.07%-83M | 62.70%-2.11B | -311.39%-5.66B | 224.11%2.68B |
-Change in inventory | 30.93%-16.3B | -250.63%-23.59B | 193.34%15.66B | -287.62%-16.78B | -194.48%-4.33B | 184.60%4.58B | -2,000.35%-5.42B | -96.57%285M | 548.70%8.31B | -131.77%-1.85B |
-Change in payables | 45.47%-17.96B | -777.76%-32.94B | 224.58%4.86B | 72.35%-3.9B | -317.61%-14.11B | -175.75%-3.38B | 65.16%4.46B | 230.20%2.7B | 273.67%818M | -108.67%-471M |
-Provision for loans, leases and other losses | -888.84%-9.83B | -90.58%1.25B | 359.08%13.23B | 4.24%-5.11B | -38.29%-5.33B | -80.82%-3.86B | 29.66%-2.13B | 36.22%-3.03B | -24.27%-4.75B | 46.85%-3.82B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -12.76%-10.04B | -18.34%-8.9B | 4.68%-7.52B | 2.04%-7.89B | 7.17%-8.05B | 8.77%-8.68B | 8.77%-9.51B | 20.78%-10.42B | 3.63%-13.16B | 13.56%-13.65B |
Interest received (cash flow from operating activities) | -2.29%4.87B | 24.10%4.98B | 84.30%4.02B | -15.64%2.18B | 6.65%2.58B | 9.99%2.42B | 6.12%2.2B | -47.13%2.08B | 110.57%3.93B | -3.57%1.86B |
Tax refund paid | 70.87%-8.22B | -1,865.57%-28.21B | 74.74%-1.44B | 67.14%-5.68B | -36.19%-17.29B | 29.51%-12.7B | -53.50%-18.01B | 12.69%-11.73B | -26.03%-13.44B | -16.26%-10.66B |
Other operating cash inflow (outflow) | 0 | -86.86%1.22B | -30.50%9.28B | 13.35B | 0 | 0 | 0 | 0 | -1M | 0 |
Operating cash flow | 12.33%150.51B | 132.84%133.99B | 325.94%57.55B | -143.71%-25.47B | -43.05%58.27B | 15.23%102.32B | 4.69%88.8B | 1.07%84.82B | -4.36%83.92B | -5.07%87.74B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -78.36%-56.37B | -223.79%-31.6B | 148.55%25.53B | 17.09%-52.58B | 12.92%-63.42B | -40.32%-72.83B | -2.30%-51.9B | -12.82%-50.74B | 14.73%-44.97B | 3.50%-52.74B |
Net business purchase and sale | 100.26%49M | -3,472.25%-19.18B | ---537M | --0 | ---- | ---- | ---- | --269M | ---- | ---- |
Net investment product transactions | -265.17%-6.65B | -68.04%4.03B | 7,770.00%12.59B | 5,233.33%160M | 101.12%3M | 89.28%-267M | -3,917.74%-2.49B | 98.48%-62M | -962.58%-4.08B | 140.10%473M |
Advance cash and loans provided to other parties | 8.58%-810M | 32.06%-886M | -122.91%-1.3B | 79.23%-585M | -738.10%-2.82B | 82.51%-336M | -330.72%-1.92B | 58.67%-446M | -148.05%-1.08B | 36.40%-435M |
Repayment of advance payments to other parties and cash income from loans | 9.58%938M | 6.20%856M | 41.40%806M | -82.08%570M | 446.56%3.18B | 37.91%582M | 83.48%422M | -90.43%230M | 212.89%2.4B | -42.64%768M |
Net changes in other investments | 32.56%6.54B | -31.23%4.94B | 11.75%7.18B | 14.43%6.42B | -35.53%5.61B | 70.77%8.71B | -45.78%5.1B | 13.73%9.4B | 44.93%8.27B | -52.75%5.71B |
Investing cash flow | -34.50%-56.3B | -194.56%-41.86B | 196.20%44.26B | 19.89%-46.01B | 10.46%-57.44B | -26.29%-64.15B | -22.86%-50.8B | -4.77%-41.34B | 14.64%-39.46B | -10.78%-46.23B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -148.24%-42.5B | 172.40%88.1B | -198.69%-121.69B | 7,019.40%123.31B | 107.05%1.73B | -18.61%-24.56B | 36.83%-20.7B | -2.34%-32.78B | -6.21%-32.03B | 67.27%-30.15B |
Net common stock issuance | 36.00%-32M | -66.67%-50M | 44.44%-30M | 28.00%-54M | -10.29%-75M | 55.84%-68M | -120.00%-154M | -110.31%-70M | 1,344.68%679M | -99.93%47M |
Increase or decrease of lease financing | -35.62%-18.31B | -124.92%-13.5B | -10.10%-6B | -16.17%-5.45B | -0.86%-4.69B | 12.57%-4.65B | -7.62%-5.32B | 3.21%-4.95B | -6.35%-5.11B | -3.51%-4.81B |
Cash dividends paid | -100.00%-9.52B | ---4.76B | ---- | 0.00%-9.52B | 0.01%-9.52B | 0.02%-9.53B | 0.00%-9.53B | 0.01%-9.53B | -0.07%-9.53B | -11.54%-9.52B |
Cash dividends for minorities | -130.19%-1.37B | -2,017.86%-593M | 92.61%-28M | 1.56%-379M | -288.89%-385M | 9.17%-99M | 9.92%-109M | -57.14%-121M | 0.00%-77M | -670.00%-77M |
Net other fund-raising expenses | 98.92%-264M | -198.16%-24.37B | 2,483,200.00%24.83B | 83.33%-1M | -500.00%-6M | 99.91%-1M | -21,380.00%-1.07B | -104.81%-5M | 42.47%104M | -85.16%73M |
Financing cash flow | -260.64%-72B | 143.55%44.82B | -195.39%-102.92B | 933.05%107.9B | 66.71%-12.95B | -5.46%-38.91B | 22.24%-36.89B | -3.23%-47.45B | -3.43%-45.96B | -17.71%-44.44B |
Net cash flow | ||||||||||
Beginning cash position | 174.78%208.19B | -0.73%75.77B | 91.82%76.32B | -23.62%39.79B | -1.28%52.09B | 1.64%52.76B | -6.69%51.91B | -2.73%55.64B | -4.99%57.2B | 28.64%60.2B |
Current changes in cash | -83.77%22.22B | 12,482.82%136.95B | -103.04%-1.11B | 400.30%36.41B | -1,552.04%-12.13B | -166.07%-734M | 127.97%1.11B | -164.62%-3.97B | 48.65%-1.5B | -122.57%-2.92B |
Effect of exchange rate changes | 349.35%11.24B | -938.10%-4.51B | 348.33%538M | 168.57%120M | -242.28%-175M | 149.00%123M | -53.99%-251M | -579.41%-163M | -73.64%34M | 104.76%129M |
Cash adjustments other than cash changes | 122.73%5M | -283.33%-22M | --12M | ---- | 98.41%-1M | -472.73%-63M | -102.67%-11M | 538.30%412M | 55.24%-94M | -153.98%-210M |
End cash Position | 16.08%241.66B | 174.78%208.19B | -0.73%75.77B | 91.82%76.32B | -23.62%39.79B | -1.28%52.09B | 1.64%52.76B | -6.69%51.91B | -2.73%55.64B | -4.99%57.2B |
Free cash flow | -7.61%93.76B | 316.46%101.48B | 130.41%24.37B | -1,166.70%-80.12B | -121.93%-6.33B | -16.15%28.85B | 9.32%34.4B | -8.45%31.47B | 1.95%34.37B | -1.56%33.72B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |